Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 1/14/2026Chinese Scientists Unveil Novel Intratumoral Vaccine
  • 1/14/2026Caldera Launches with $112.5 Million to Advance China-Licensed IBD Bs...
  • 1/14/2026Pfizer Announces Completion of Key China Phase 3 Trial for Migraine Dr...
  • 1/14/2026NHSA Seeks Feedback on Draft Guidelines for Real-World Drug Value Ass...
  • 1/14/2026Sino Biopharma Completes Full Acquisition of Hygieia for CNY 1.2B
  • 1/14/2026Signet Thera Raises CNY 80M in Series A
  • 1/14/2026XellSmart Completes Series C1 Financing
  • 1/14/2026GenHouse Bio Secures CNY 300M+ in Crossover Financing
  • 1/13/2026Vibrant Thera Raises $61M to Advance Logic-Gated Cancer Immunotherapie...
  • 1/13/2026Abbisko's Pimicotinib Advances Toward U.S. Approval as FDA Accepts NDA
  • 1/13/2026Novartis Expands Radioligand Therapy Pipeline with Licensing Deal from...
  • 1/13/2026China Weighs Approval of Russian Cancer Vaccine, Eyes Broader Pharma C...
  • 1/12/2026Anticancer Bioscience Secures Angel Funding to Advance Precision Oncol...
  • 1/12/2026Eli Lilly Submits Orforglipron NDA in China for GLP-1R Agonist
  • 1/12/2026AbbVie Secures Global Rights to RemeGen’s PD-1/VEGF Bispecific RC148 ...
  • 1/12/2026SciNeuro and Novartis Forge $1.5B Collaboration on Next-Gen Alzheimer'...
  • 1/12/2026Zonsen PepLib Signs $50M Licensing Deal with Novartis for Radioligand ...
  • 1/12/2026Oricell Raises $70M to Fast‑Track Global CAR‑T Programs
  • 1/12/2026Zenitar Raises ~CNY 600M in Major Series C Financing
  • 1/12/2026Recordati Folds Operations in China
  • 1/12/2026Henlius Reports Promising Phase 2 Results for PD-L1 ADC HLX43
  • 1/9/2026AirNexis Launches with $200M to Advance China-Origin COPD Therapy
  • 1/9/2026Recent Executive Moves
  • 1/9/2026China Rolls Out Smart Medical Insurance Payments to Improve Access
  • 1/9/2026China Expands Cross-Province Use of Employee BMI Funds for Family Memb...
  • 1/9/2026NHSA Seeks Comments on Draft Rules for Early Communication on Comparat...
  • 1/9/2026China Issues New Procedures for Post-Approval Filing Changes to Overse...
  • 1/9/2026Hengrui Secures China Approval for Retlirafusp Alfa for Gastric Cancer
  • 1/9/2026MediLink and Roche Expand Partnership with Exclusive Global License fo...
  • 1/8/2026BMS/Biokin's ADC Hits Phase III Milestone in Advanced NPC
  • Page:1/59 Total number of articles:1743: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group